Collegium Pharmaceutical Inc (COLL)
33.99
+0.70
(+2.10%)
USD |
NASDAQ |
May 15, 15:59
Collegium Pharmaceutical Cash from Operations (Quarterly): 61.94M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 61.94M |
| December 31, 2023 | 73.34M |
| September 30, 2023 | 74.02M |
| June 30, 2023 | 99.72M |
| March 31, 2023 | 27.67M |
| December 31, 2022 | 66.32M |
| September 30, 2022 | 42.77M |
| June 30, 2022 | 40.45M |
| March 31, 2022 | -25.32M |
| December 31, 2021 | 36.20M |
| September 30, 2021 | 17.25M |
| June 30, 2021 | 29.54M |
| March 31, 2021 | 20.57M |
| December 31, 2020 | 22.58M |
| September 30, 2020 | 34.18M |
| June 30, 2020 | 43.85M |
| March 31, 2020 | -6.669M |
| December 31, 2019 | 15.66M |
| September 30, 2019 | 6.069M |
| June 30, 2019 | 14.63M |
| March 31, 2019 | -8.569M |
| Date | Value |
|---|---|
| December 31, 2018 | 42.29M |
| September 30, 2018 | 41.83M |
| June 30, 2018 | 55.60M |
| March 31, 2018 | 29.66M |
| December 31, 2017 | -13.30M |
| September 30, 2017 | -12.57M |
| June 30, 2017 | -17.47M |
| March 31, 2017 | -23.69M |
| December 31, 2016 | -23.29M |
| September 30, 2016 | -19.41M |
| June 30, 2016 | -20.84M |
| March 31, 2016 | -11.52M |
| December 31, 2015 | -8.939M |
| September 30, 2015 | -6.536M |
| June 30, 2015 | -4.411M |
| March 31, 2015 | -1.681M |
| December 31, 2014 | -7.567M |
| September 30, 2014 | -4.408M |
| June 30, 2014 | -2.201M |
| March 31, 2014 | -3.771M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.32M
Minimum
Mar 2022
99.72M
Maximum
Jun 2023
34.74M
Average
31.86M
Median
Cash from Operations (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 31.92M |
| Supernus Pharmaceuticals Inc | 38.40M |
| AnaptysBio Inc | -37.25M |
| Recursion Pharmaceuticals Inc | -102.30M |
| Nuvalent Inc | -36.09M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -18.13M |
| Cash from Financing (Quarterly) | -54.15M |
| Free Cash Flow | 308.16M |
| Free Cash Flow Per Share (Quarterly) | 1.481 |
| Free Cash Flow to Equity (Quarterly) | 105.42M |
| Free Cash Flow to Firm (Quarterly) | 71.09M |
| Free Cash Flow Yield | 19.28% |